![Glenn L. Cooper](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Glenn L. Cooper
Chairman at Lascaux Media LLC
Glenn L. Cooper active positions
Companies | Position | Start | End |
---|---|---|---|
Lascaux Media LLC | Chairman | - | - |
Career history of Glenn L. Cooper
Former positions of Glenn L. Cooper
Companies | Position | Start | End |
---|---|---|---|
REPLIGEN CORPORATION | Director/Board Member | 24/08/2009 | 12/05/2020 |
Independent Dir/Board Member | 24/08/2009 | 12/05/2020 | |
GENTIUM S.P.A. (ADR) | Director/Board Member | 09/11/2009 | 26/03/2013 |
Independent Dir/Board Member | 30/09/2009 | 26/03/2013 | |
FORTRESS BIOTECH, INC. | Director/Board Member | 29/07/2010 | 30/11/2010 |
Chief Executive Officer | 30/11/2010 | 31/03/2011 | |
Chairman | 30/11/2010 | 01/01/2013 | |
Indevus Pharmaceuticals, Inc.
![]() Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Director/Board Member | 31/12/1992 | 15/12/1996 |
Chief Executive Officer | 15/12/1996 | 31/12/2008 | |
Chairman | 15/12/1996 | 31/12/2008 | |
Progenitor, Inc.
![]() Progenitor, Inc. BiotechnologyHealth Technology Progenitor, Inc. is an American private company. The firm develops pharmaceutical compounds for nervous system. The company is headquartered in Columbus, OH. | President | 31/08/1992 | 31/05/1994 |
Lilly Research Center Ltd.
![]() Lilly Research Center Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly Research Center Ltd. is a British company. | Corporate Officer/Principal | 31/05/1987 | 30/06/1990 |
Sphinx Pharmaceuticals Corp | Chief Operating Officer | 31/07/1990 | - |
Training of Glenn L. Cooper
Harvard College | Undergraduate Degree |
Tufts University School of Medicine | Doctorate Degree |
Statistics
International
United States | 9 |
United Kingdom | 2 |
Italy | 2 |
Operational
Director/Board Member | 4 |
Chairman | 3 |
Independent Dir/Board Member | 2 |
Sectoral
Health Technology | 8 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
REPLIGEN CORPORATION | Health Technology |
FORTRESS BIOTECH, INC. | Health Technology |
Private companies | 6 |
---|---|
Progenitor, Inc.
![]() Progenitor, Inc. BiotechnologyHealth Technology Progenitor, Inc. is an American private company. The firm develops pharmaceutical compounds for nervous system. The company is headquartered in Columbus, OH. | Health Technology |
Sphinx Pharmaceuticals Corp | Health Technology |
Lilly Research Center Ltd.
![]() Lilly Research Center Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly Research Center Ltd. is a British company. | Health Technology |
Gentium Srl
![]() Gentium Srl Pharmaceuticals: MajorHealth Technology Gentium SRL manufactures and develops biopharmaceutical products. It offers discovery, research, development and manufacture of drugs for the treatment and prevention of a variety of vascular diseases and conditions related to cancer and cancer treatments. The company was founded by Laura Iris Ferro and is headquartered in Villa Guardia, Italy. | Health Technology |
Indevus Pharmaceuticals, Inc.
![]() Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Health Technology |
Lascaux Media LLC |
- Stock Market
- Insiders
- Glenn L. Cooper
- Experience